Tracking 45+ Companies & 136+ Open Roles
The career platform for psychedelic medicine
Company intelligence, jobs, clinical trials, and practitioner resources — everything you need to build a career in the emerging psychedelic industry.
45+
Companies tracked
136+
Open positions
2445
Active clinical trials
17
States with legislation
Mohsen SaidinejadSub-dissociative · Sickle Cell DiseasePhase 2·
Baylor College of MedicinePsilocybin 15mg · PTSDPhase 2·
University Medical Center GroningenPsilocybin therapy · COPD (Chronic Obstructive Pulmonary Disease)Phase 2·
University Health Network, TorontoSingle · Major Depressive DisorderPhase 2·
Definium Therapeutics US, Inc.DT402 · Autism Spectrum DisorderPhase 2·
Stanford UniversityKetamine · Obsessive-Compulsive DisorderPhase 2·
University of Texas Southwestern Medical CenterKetamine · Substance Use DisordersPhase 2·
Icahn School of Medicine at Mount SinaiIV Ketamine · DepressionPhase 2·
Jason SperryKetamine · Traumatic InjuryPhase 3·
Definium Therapeutics US, Inc.MM120 · Generalized Anxiety DisorderPhase 3·
Mohsen SaidinejadSub-dissociative · Sickle Cell DiseasePhase 2·
Baylor College of MedicinePsilocybin 15mg · PTSDPhase 2·
University Medical Center GroningenPsilocybin therapy · COPD (Chronic Obstructive Pulmonary Disease)Phase 2·
University Health Network, TorontoSingle · Major Depressive DisorderPhase 2·
Definium Therapeutics US, Inc.DT402 · Autism Spectrum DisorderPhase 2·
Stanford UniversityKetamine · Obsessive-Compulsive DisorderPhase 2·
University of Texas Southwestern Medical CenterKetamine · Substance Use DisordersPhase 2·
Icahn School of Medicine at Mount SinaiIV Ketamine · DepressionPhase 2·
Jason SperryKetamine · Traumatic InjuryPhase 3·
Definium Therapeutics US, Inc.MM120 · Generalized Anxiety DisorderPhase 3·
Companies
The psychedelic medicine ecosystem
Stay ahead of the industry
Get updates on new job listings, clinical trial progress, and regulatory changes across all 50 states.